United States

Xiangxue Pharmaceutical Co Ltd (300147.SZ)

300147.SZ on Shenzhen Stock Exchange

Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for 300147.SZ


Xiangxue Pharmaceutical Co., Ltd. is principally engaged in the production and distribution of Chinese patent medicine. The Company provides tablets, capsules, granules, oral liquids and aerosols, among others. The Company's major products include antiviral oral liquids and indigowoad root granules. The Company distributes its... (more)


Beta: 0.84
Market Cap(Mil.): ¥7,917.87
Shares Outstanding(Mil.): 661.48
Dividend: 0.12
Yield (%): 1.00


  300147.SZ Industry Sector
P/E (TTM): 80.22 28.39 29.32
EPS (TTM): 0.15 -- --
ROI: 3.21 13.54 13.03
ROE: 3.21 14.43 14.17

BRIEF-Xiangxue Pharmaceutical's joint project passes FDA approval

* Says the co's project partner, Sirnaomics,lnc., received approval from the U.S Food and Drug Administration (FDA) for the joint project on pharmaceutical research of scar treatment Cotsiranib

Nov 08 2016

BRIEF-Xiangxue Pharmaceutical to set up life insurance JV

* Says it plans to invest 160 million yuan to set up life insurance firm with registered capital at 1.0 billion yuan

Oct 21 2016

BRIEF-Xiangxue Pharma signs framework agreement on Chinese medicine related projects

* Says it signs framework agreement on chinese medicine related projects with investment of 750 million yuan ($111.35 million)

Oct 19 2016

BRIEF-Xiangxue Pharmaceutical sees 2016 Q1~Q3 net profit to decrease by 35 pct to 50 pct

* sees 2016 Q1~Q3 net profit to decrease by 35 percent to 50 percent, compared to net profit of Q1~Q3 in 2015(145.1 million yuan)

Oct 14 2016

BRIEF-Xiangxue Pharmaceutical issues 2016 1st tranche super short-term financing notes worth 750 mln yuan

* Says it issues 2016 first tranche super short-term financing notes worth 750 mln yuan, with a term of 270 days and coupon rate of 3.39 percent

Aug 29 2016

More From Around the Web

Earnings vs. Estimates